Amorphous forms of risedronate monosodium

Details Amorphous forms of risedronate monosodium Amorphous forms of risedronate monosodium

2005-02-28

2009-11-17

Morris, Patricia L (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Phosphorus containing other than solely as part of an...

C546S022000

Reexamination Certificate

active

07618953

ABSTRACT:
The monosodium salt of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid in new amorphous forms, methods of preparation and a pharmaceutical formulation.

REFERENCES:
patent: 6410520 (2002-06-01), Cazer et al.
patent: 2005/0215793 (2005-09-01), Turchetta et al.
patent: 2006/0148762 (2006-07-01), Richter et al.
patent: 98 57967 (1998-12-01), None
patent: 01 56983 (2001-08-01), None
Brittain et al., Polymorphism in Pharmaceutical Sciences, NY:Marcel Dekker pp. 1-2, 183-226).
Threifall et al., “Analysis of Organic, etc.,” Analyst, 1995, 120, 2435-2460.
Muzaffar et al., “Polymorphism and Drug, etc.,” J of Pharmacy (Lahore). 1979, 1(1), 59-66.
Doelker, english translation of S.T.P. Pharma Pratiques (1999), 9(5), 299-409, pp. 1-33.
Xu ,“An easy and primary, etc.,” J of Zhejiang University of Technology, 31 (4), 2003, 456-459.
Lester et al., “Dehydration of, etc.,” J of Pharmaceutical Sciences, 95 (12), 2006, 2631-2644.
Singhal et al., “Drug Polymorphism, etc.,” Advanced Drug Delivery Reviews 56 (2004) 335-347.
U.S. Pharmacopia #23, National Formulary # 18 (1995) 1843-1844.
Bernstein et al., “Polymorphism in, etc.,” Oxford: Clarendon Press, 2002, pp. 117,118,272 and 273.
Davidovich et al., “Detection of, etc.,” American Pharmaceutical Review, IN: Russell Pub., 2004, 7(1), pp. 10,12,14,16 and 100.
Mehta, Surendra C.,“Issues and Approaches for Improving the Solubiliti and Bioavailability of Poorly Water Soluble Compounds”, Bulletin Technique Gattefosse Report, vol. 91, No. 91, pp. 65-72, 1998.

Affiliated with

Also associated with

Rating

Amorphous forms of risedronate monosodium does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Amorphous forms of risedronate monosodium, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amorphous forms of risedronate monosodium will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4100508